No Data
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
RBC Capital Sticks to Its Buy Rating for Medtronic (MDT)
Diabetes Device Maker Beta Bionics Files for $100M IPO
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Fire1 Raises $120M for Breakthrough Heart Failure Management Tech With Investment From Medtronic
Buy n Die Together❤ :
watuzzi : lets goo
72368432 :
TRIUMPHANT RETURNS :
Ryu983 :
View more comments...